Publications by authors named "Stephane Guerif"

Claim this Profile
V
Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia.
Jessica Liegel, Dina Stroopinsky, Giulia Cheloni, Dimitra Karagkouni, Myrna Nahas, Stephane Guerif

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial.
Nicolas Demogeot, Paul Sargos, Julia Salleron, Stéphane Guérif, Renaud de Crevoisier

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile.
Zhihong Zeng, Annelies Roobrouck, Geert Deschamps, Helene Bonnevaux, Stephane Guerif

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment.
Hélène Bonnevaux, Stephane Guerif, Jana Albrecht, Erwan Jouannot, Thibaud De Gallier

Oncoimmunology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities.
Céline Nicolazzi, Anne Caron, Alexia Tellier, Marc Trombe, Jan Pinkas

Mol Cancer Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, Stéphane Guerif

Lancet Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reoxygenation during radiotherapy in intermediate-risk prostate cancer.
Stéphane Supiot, Caroline Rousseau, Mélanie Dore, Catherine Chèze-Le-Rest, Christine Kandel-Aznar, Stéphane Guerif

Radiother Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using F-fluoromisonidazole PET/CT: a pilot study.
Stéphane Supiot, Caroline Rousseau, Mélanie Dore, Catherine Cheze-Le-Rest, Christine Kandel-Aznar, Stéphane Guerif

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?
Igor Latorzeff, Paul Sargos, Geneviève Loos, Stéphane Supiot, Stéphane Guerif

Front Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.
Florent Vilotte, Mickael Antoine, Maxime Bobin, Igor Latorzeff, Stéphane Supiot

Front Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-PKcs Expression Is a Predictor of Biochemical Recurrence After Permanent Iodine 125 Interstitial Brachytherapy for Prostate Cancer.
Sarah Molina, Stéphane Guerif, Alexandre Garcia, Céline Debiais, Jacques Irani

Int J Radiat Oncol Biol Phys· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Christian Carrie, Ali Hasbini, Guy de Laroche, Pierre Richaud, Stéphane Guerif

Lancet Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Paul Sargos, Stéphane Guerif, Igor Latorzeff, Christophe Hennequin, Pascal Pommier

Cancer Treat Rev· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression.
Shaomeng Wang, Wei Sun, Yujun Zhao, Donna McEachern, Isabelle Meaux, Stéphane Guerif

Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomograms to predict late urinary toxicity after prostate cancer radiotherapy.
Romain Mathieu, Juan David Ospina Arango, Véronique Beckendorf, Jean-Bernard Delobel, Taha Messai, Stéphane Guerif

World J Urol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers.
Victor Certal, Jean-Christophe Carry, Frank Halley, Angela Virone-Oddos, Fabienne Thompson, Stephane Guerif

J Med Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfaction.
Thierry Lebret, Jean-Loup Mouysset, Alain Lortholary, Claude El Kouri, Laurent Bastit

Support Care Cancer· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfaction].
Thierry Lebret, Jean-Loup Mouysset, Alain Lortholary, Claude El Kouri, Laurent Bastit

Bull Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-PKcs expression predicts response to radiotherapy in prostate cancer.
Patrick Bouchaert, Stephane Guerif, Celine Debiais, Jacques Irani, Gaelle Fromont

Int J Radiat Oncol Biol Phys· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
Jean Bourhis, Christian Sire, Pierre Graff, Vincent Grégoire, Philippe Maingon, Stéphane Guerif

Lancet Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.
François Vallée, Chantal Carrez, Fabienne Pilorge, Alain Dupuy, Annick Parent, Stéphane Guerif

J Med Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
7
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.
Véronique Beckendorf, Stéphane Guerif, Elisabeth Le Prisé, Jean-Marc Cosset, Agnes Bougnoux

Int J Radiat Oncol Biol Phys· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
George van Andel, Andrew Bottomley, Sophie D Fosså, Fabio Efficace, Corneel Coens, Stephane Guerif

Eur J Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[T1-T2 prostate cancer: treatment by radiation therapy].
Jean-Léon Lagrange, Stéphane Guerif

Bull Cancer· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study.
Catherine Buron, Beatrice Le Vu, Jean-Marc Cosset, Pascal Pommier, Didier Peiffert, Stephane Guerif

Int J Radiat Oncol Biol Phys· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis